Navigation Links
Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
Date:11/1/2010

fused FVIII represents the most devastating complication in modern hemophilia A replacement therapy. The human glycosylation pattern in Human-cl rhFVIII might make it possible to avoid potentially immunogenic epitopes as expressed by hamster cells. Although clinical data have not yet been reviewed and verified by the U.S. Food and Drug Administration, the study aims to show an improved safety and long-term reduced immunogenicity of Human-cl  rhFVIII.

Human-cl rhFVIII is concentrated and purified for virus inactivation/removal although the cell bank and end of production cells have been extensively tested to ensure they are free of any endogenous or infectious viruses. The process ensures that any theoretical virus contamination is safely inactivated and/or removed. The manufacturing of Human-cl rhFVIII is completely free of animal or human derived added materials. The clinical development plan for Human-cl rhFVIII follows the requirements of the U.S. Food and Drug Administration and European guidelines.

About the Octapharma Group

Headquartered in Lachen, Switzerland, Octapharma AG is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for over 27 years. Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell-lines, including immune globulin intravenous (IGIV). In the U.S., Octapharma's IGIV product, octagam® (immune globulin intravenous [human] 5%), is used to treat disorders of the immune system, and Octapharma's Albumin (Human)® is indicated for the restoration and mai
'/>"/>

SOURCE Octapharma USA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
2. Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
3. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
4. Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
5. Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
6. Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
7. Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease
8. FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USAs New Therapy for Common Inherited Bleeding Disorder
9. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
10. Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BEDFORD, Massachusetts , 17. September ... HOLX ), hat heute ... Gerät zur präanalytischen Probenverarbeitung, in Europa ... CE-IVD gekennzeichnete, vollautomatisierte Universalplattform zur Vereinfachung ... erreicht, dass ineffiziente und fehlerbehaftete Arbeitsschritte ...
(Date:9/16/2014)... CLEMENTE, Calif. , Sept. 16, 2014 /PRNewswire/ ... CONTROL-HTN trial, an international multi-center, prospective, randomized, controlled, ... the treatment of arterial hypertension. The CONTROL-HTN trial, NCT01642498, ... procedure creating a fixed connection between a central ... for the treatment of hypertension. The primary outcomes ...
(Date:9/16/2014)... OAKLAND, Calif. , Sept. 16, 2014  Chairman ... that Richard (Dick) Daniels will assume the ... Foundation Hospitals and Health Plan, Inc., effective immediately. ... developing and implementing technological advancements that advance the high-quality ... members," Tyson said. " Dick Daniels has extensive ...
Breaking Medicine Technology:Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial 2Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2
... Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific ... measure and improve quality in the cath lab for ... of using evidence to guide new ways to advance ... quality program with its signature "Quality Improvement Toolkit" to ...
... Bank Pharmaceuticals today announced it has been awarded an ... Institute of Allergy and Infectious Diseases for the development ... treatment of Hepatitis B virus infection.   Under ... $3.9 million over five years in support of its development ...
Cached Medicine Technology:SCAI Announces National Quality Program to Improve Cardiovascular Patient Care 2SCAI Announces National Quality Program to Improve Cardiovascular Patient Care 3SCAI Announces National Quality Program to Improve Cardiovascular Patient Care 4Spring Bank Pharmaceuticals Awarded $3.9 Million RO1 NIH Grant to Advance Innovative Hepatitis Program 2
(Date:9/17/2014)... Detroit, MI (PRWEB) September 17, 2014 ... are excited to be of the first in ... Ultherapy Décolletage Treatment, specifically designed to minimize the appearance ... Ultherapy, made waves in 2012 with the first FDA-cleared ... and face, and now they have expanded their brand ...
(Date:9/17/2014)... PHILIPPINES (PRWEB) September 17, 2014 MicroSourcing ... and Business Process Outsourcing (BPO) services in the Philippines, ... as the Senior Vice President – North America to ... Cary Weltken is a 15 year veteran of the ... experience in helping companies, ranging in size from small ...
(Date:9/17/2014)... 2014 Presence Technology, a multinational ... Presence Suite 10.0, which incorporates significant enhancements to ... experience. , The Contact Center Agents and Supervisors ... can get a better feel for the performance ... most and who requires additional coaching or mentoring ...
(Date:9/16/2014)... 17, 2014 A nice seat cover is ... interior appearances. The quality covers offered by Lseat.com have every ... vehicles, while keeping the cars protected from everyday wear and ... range of Chevrolet leather seat covers and launched ... made of a comfortable mesh fabric that is both washable ...
(Date:9/16/2014)... September 17, 2014 Keep that sexy decolletage ... on the neck. , "The Face Whisperer Neck & ... says Kathy Heshelow, founder of Sublime Beauty®. "It contains rich ... aloe, MSM and arnica." , A special ingredient is Argireline, ... , The rich anti-aging cream comes in an airless pump ...
Breaking Medicine News(10 mins):Health News:FACE Skincare Medical Wellness Debuts Ultherapy Décolletage Treatment 2Health News:MicroSourcing Appoints New Senior Vice President of North America 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Lseat.com: 2006-2014 Chevrolet Tahoe Chevrolet Tahoe Leather Seat Covers At Discounted Rates 2Health News:15% Off Face Whisperer® Neck & Decollete Cream Now from Sublime Beauty; Care For This Delicate Skin That Shows Age Quickly 2
... Mylan Pharmaceuticals Inc. has received final approval from the ... Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules ... generic version of Eli Lilly and Company's Prozac(R) Capsules. ... for the 12 months ending March 31, 2007, for ...
... set high staffing standards for elder care in nursing homes ... staff nurses to prevent serious safety violations, according to ... of Nursing. ,The majority of the nation's elderly ... is well below national recommendations for safe care, the study ...
... ocean measurements and by analysing climate simulations we can see ... be explained by natural variability',said CSIRO oceanographer Dr Gael Alory. ... to changes in the heat structure of the atmosphere and ... sub-tropical Indian Ocean of around two degrees celsius. ...
... brand ambassadors of India. But they could also prove a ... case of Thirumurthy Nakka Boomaiah , 35 and hailing ... ,He has been sentenced to 69 days in ... London to Philadelphia and assaulting flight attendants. But he has ...
... during pregnancy could be harmful, according to an Iranian university ... anemia in pregnancy but many women take extra iron. Anemia ... enough oxygen due to low number of red blood cells ... normal amounts of oxygen. Common symptoms of anemia include feeling ...
... who were treated at Presbyterian Hospital of Dallas for ... the hospital and doctors there took part in a ... women's problems. ,According to the complaint filed ... a patient in Presbyterian's Eating Disorder Program. There, psychiatrist ...
Cached Medicine News:Health News:Policy Changes Have Direct Effect on Nursing Home Care 2Health News:Policy Changes Have Direct Effect on Nursing Home Care 3Health News:Climate Change Signal Detected in the Indian Ocean 2Health News:Indian Engineer Sentenced for Groping Women During Flight 2Health News:Anorexia Patients Sue Dallas' Presbyterian Hospital 2
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
... cover the range from 2ul to 5000ul. ... lock design prevents inadvertent volume change. Novel ... Whole pipette is autoclavable at 121C(250F). To ... Suitable for one-handed operation. Auto or ...
Medicine Products: